Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1995 1
2001 1
2003 1
2005 1
2006 7
2007 4
2008 4
2009 4
2010 3
2011 7
2012 4
2013 5
2014 6
2015 2
2016 1
2017 2
2018 2
2019 2
2020 9
2021 7
2022 8
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Molecular genetics in 4408 cardiomyopathy probands and 3008 relatives in Norway: 17 years of genetic testing in a national laboratory.
Stava TT, Leren TP, Bogsrud MP. Stava TT, et al. Eur J Prev Cardiol. 2022 Oct 18;29(13):1789-1799. doi: 10.1093/eurjpc/zwac102. Eur J Prev Cardiol. 2022. PMID: 35653365
A likely pathogenic or pathogenic variant (216 different variants including 67 novel) was detected in 574 probands, corresponding to a hit-rate of genetic testing of 13.1% in total, 11.9% in hypertrophic, 14.1% in dilated, and 14.9% in arrhythmogenic right ventri …
A likely pathogenic or pathogenic variant (216 different variants including 67 novel) was detected in 574 probands, corresponding to a hit-r …
Genetic profile and genotype-phenotype correlations in childhood cardiomyopathy.
Wanert C, El Louali F, Al Dybiat S, Nguyen K, Zaffran S, Ovaert C. Wanert C, et al. Arch Cardiovasc Dis. 2023 Jun-Jul;116(6-7):309-315. doi: 10.1016/j.acvd.2023.04.008. Epub 2023 May 16. Arch Cardiovasc Dis. 2023. PMID: 37246080
Patients were classified into six groups: hypertrophic cardiomyopathy; dilated cardiomyopathy; restrictive cardiomyopathy; left ventricular non-compaction; arrhythmogenic right ventricular dysplasia; and mixed cardiomyopathy. ...Among 64 patient …
Patients were classified into six groups: hypertrophic cardiomyopathy; dilated cardiomyopathy; restrictive cardiomyopathy; left ventricul …
Diagnostic Criteria, Genetics, and Molecular Basis of Arrhythmogenic Cardiomyopathy.
Basso C, Pilichou K, Bauce B, Corrado D, Thiene G. Basso C, et al. Heart Fail Clin. 2018 Apr;14(2):201-213. doi: 10.1016/j.hfc.2018.01.002. Heart Fail Clin. 2018. PMID: 29525648 Review.
Arrhythmogenic cardiomyopathy (AC) is an inherited heart muscle disease characterized by myocardial atrophy and fibrofatty replacement of the ventricular myocardium, at risk of sudden cardiac death, particularly in the young and athletes. ...
Arrhythmogenic cardiomyopathy (AC) is an inherited heart muscle disease characterized by myocardial atrophy and fibrofatty replacemen …
Differential diagnosis of arrhythmogenic cardiomyopathy: phenocopies versus disease variants.
Cipriani A, Perazzolo Marra M, Bariani R, Mattesi G, Vio R, Bettella N, DE Lazzari M, Motta R, Bauce B, Zorzi A, Corrado D. Cipriani A, et al. Minerva Med. 2021 Apr;112(2):269-280. doi: 10.23736/S0026-4806.20.06782-8. Epub 2020 Jul 22. Minerva Med. 2021. PMID: 32700864 Review.
Arrhythmogenic cardiomyopathy (ACM) is a genetic heart muscle disease caused by mutations of desmosomal genes in about 50% of patients. ...This article reviews the clinical and imaging features of major phenocopies of ACM and provides indications for differential diagnosis …
Arrhythmogenic cardiomyopathy (ACM) is a genetic heart muscle disease caused by mutations of desmosomal genes in about 50% of patient …
A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression.
Chen L, Song J, Chen X, Chen K, Ren J, Zhang N, Rao M, Hu Z, Zhang Y, Gu M, Zhao H, Tang H, Yang Z, Hu S. Chen L, et al. Eur Heart J. 2019 Jun 1;40(21):1690-1703. doi: 10.1093/eurheartj/ehz172. Eur Heart J. 2019. PMID: 30945739
Patients in Cluster 1 mainly carried desmosomal mutations (except for desmoplakin) and were subjected to transplantation at early age; this group was consistent with classical 'desmosomal cardiomyopathy'. Cluster 2 mostly had non-desmosomal mutations and showed regional fi …
Patients in Cluster 1 mainly carried desmosomal mutations (except for desmoplakin) and were subjected to transplantation at early age; this …
Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy.
Christensen AH, Platonov PG, Svensson A, Jensen HK, Rootwelt-Norberg C, Dahlberg P, Madsen T, Frederiksen TC, Heliö T, Haugaa KH, Bundgaard H, Svendsen JH. Christensen AH, et al. Europace. 2022 Feb 2;24(2):306-312. doi: 10.1093/europace/euab112. Europace. 2022. PMID: 34279601
AIMS: Treatment with implantable cardioverter-defibrillators (ICD) is a cornerstone for prevention of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy (ARVC). We aimed at describing the complications associated with ICD treatment in a m …
AIMS: Treatment with implantable cardioverter-defibrillators (ICD) is a cornerstone for prevention of sudden cardiac death in arrhythmoge …
Predicting ventricular tachycardia circuits in patients with arrhythmogenic right ventricular cardiomyopathy using genotype-specific heart digital twins.
Zhang Y, Zhang K, Prakosa A, James C, Zimmerman SL, Carrick R, Sung E, Gasperetti A, Tichnell C, Murray B, Calkins H, Trayanova NA. Zhang Y, et al. Elife. 2023 Oct 18;12:RP88865. doi: 10.7554/eLife.88865. Elife. 2023. PMID: 37851708 Free PMC article.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic cardiac disease that leads to ventricular tachycardia (VT), a life-threatening heart rhythm disorder. Treating ARVC remains challenging due to the complex underlying arrhythmogenic …
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic cardiac disease that leads to ventricular ta …
Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment.
Kiès P, Bootsma M, Bax J, Schalij MJ, van der Wall EE. Kiès P, et al. Heart Rhythm. 2006 Feb;3(2):225-34. doi: 10.1016/j.hrthm.2005.10.018. Heart Rhythm. 2006. PMID: 16443541 Review.
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a heart muscle disorder characterized pathologically by fatty or fibrofatty replacement and electrical instability of the right ventricular myocardium. Clinical manifes …
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a heart muscle disorder characterized path …
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
Protonotarios A, Bariani R, Cappelletto C, Pavlou M, García-García A, Cipriani A, Protonotarios I, Rivas A, Wittenberg R, Graziosi M, Xylouri Z, Larrañaga-Moreira JM, de Luca A, Celeghin R, Pilichou K, Bakalakos A, Lopes LR, Savvatis K, Stolfo D, Dal Ferro M, Merlo M, Basso C, Freire JL, Rodriguez-Palomares JF, Kubo T, Ripoll-Vera T, Barriales-Villa R, Antoniades L, Mogensen J, Garcia-Pavia P, Wahbi K, Biagini E, Anastasakis A, Tsatsopoulou A, Zorio E, Gimeno JR, Garcia-Pinilla JM, Syrris P, Sinagra G, Bauce B, Elliott PM. Protonotarios A, et al. Eur Heart J. 2022 Aug 21;43(32):3053-3067. doi: 10.1093/eurheartj/ehac235. Eur Heart J. 2022. PMID: 35766183 Free PMC article.
AIMS: To study the impact of genotype on the performance of the 2019 risk model for arrhythmogenic right ventricular cardiomyopathy (ARVC). METHODS AND RESULTS: The study cohort comprised 554 patients with a definite diagnosis of ARVC and no history of sustai …
AIMS: To study the impact of genotype on the performance of the 2019 risk model for arrhythmogenic right ventricular ca …
Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies.
Corrado D, Basso C, Nava A, Thiene G. Corrado D, et al. Cardiol Rev. 2001 Sep-Oct;9(5):259-65. doi: 10.1097/00045415-200109000-00005. Cardiol Rev. 2001. PMID: 11520449 Review.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease of unknown etiology characterized by the peculiar right ventricular (RV) involvement. ...Later in the disease evolution, progression and extension of RV muscle dise …
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease of unknown etiology characterized by t …
74 results